The goal of this study was laboratory testing for hypercoagulability in patients with solid tumors using rotation thrombelastogram (ROTEM®) and correlate ROTEM® parameters with routine coagulation tests. A total of 78 untreated patients with cancer were included: 28 gastrointestinal system tumors (group 1), 27 respiratory system tumors (group 2), and 23 miscellaneus group of ovarian, renal, nasopharyngeal, mesothelioma, and unknown origin (group 3). Platelet count was significantly increased in group 2 in respect to group 3 (P < 0.05) and fibrinogen level was significantly increased in group 2 in respect to group 1 (P < 0.05). There was no statistically significant difference between subgroups in respect to TEG parameters. Tumor-node-metastasis (TNM) stages of patients was not also associated with either of TEG parameters. Correlation analysis revealed significant correlation between laboratory parameters and ROTEM® parameters. Fibrinogen showed the strongest correlation with MCF (r > 0.7) and CFT in all assays (INTEM, EXTEM, FIBTEM, APTEM). There were also statistically significant correlations between platelet number and other ROTEM® parameters (INTEM-CFT, -MCF, EXTEM-CFT, -MCF, FIBTEM-MCF, APTEM-CFT, -MCF). In conclusions, our data demonstrates thromboelastographic signs of hypercoagulability in patients with solid tumors. ROTEM® is able to identify the contribution of fibrinogen and platelets to clot strength in this patient population.
Thrombelastography Thrombosis Cancer
This is a preview of subscription content, log in to check access.
Troussea A. Phlegmasia alba dolens. In: Peter M, editor. Clinique Medicale de l’Hotel-Dieu de Paris. Paris: Bailliere JB et Fils; 1877. p. 695–739.Google Scholar
Nijziel MR, van Oerle R, Hillen HFP, Hamulyak K. From Trousseau to angiogenesis: the link between the hemostatic system and cancer. Neth J Med. 2006;64(11):403–10.PubMedGoogle Scholar
Sun NC, McAfee WM, Hum GJ, Weiner JM. Hemostatic abnormalities in malignancy, a prospective study in one hundred eight patients. Part I. Coagulation study. Am J Clin Pathol. 1979;71:10–6.PubMedGoogle Scholar
Edwards RL, Rickles FR, Moritz TE, Henderson WG, Zacharski LR, et al. Abnormalities of blood coagulation tests in patients with cancer. Am J Clin Pathol. 1987;88:596–602.PubMedGoogle Scholar